UPDATE 1-Roche says Tecentriq cocktail helps liver cancer patients live longer
Swiss drugmaker Roche on
Friday said its immunotherapy Tecentriq combined with its
Avastin medicine helped people with the most common form of
liver cancer to live longer than with an older drug from
Germany’s Bayer.
Friday said its immunotherapy Tecentriq combined with its
Avastin medicine helped people with the most common form of
liver cancer to live longer than with an older drug from
Germany’s Bayer.
Posted by Reuters
